vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and ThredUp Inc. (TDUP). Click either name above to swap in a different company.

ThredUp Inc. is the larger business by last-quarter revenue ($79.7M vs $62.1M, roughly 1.3× Cytek Biosciences, Inc.). ThredUp Inc. runs the higher net margin — -7.0% vs -70.9%, a 63.9% gap on every dollar of revenue. On growth, ThredUp Inc. posted the faster year-over-year revenue change (18.5% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-3.2M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 11.1%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

ThredUp Inc. is an American company that operates an online resale platform specializing in the sale of second-hand clothing, footwear, and accessories. Founded in 2009 and headquartered in Oakland, California, it has established itself as one of the leading resale fashion marketplaces.

CTKB vs TDUP — Head-to-Head

Bigger by revenue
TDUP
TDUP
1.3× larger
TDUP
$79.7M
$62.1M
CTKB
Growing faster (revenue YoY)
TDUP
TDUP
+10.4% gap
TDUP
18.5%
8.1%
CTKB
Higher net margin
TDUP
TDUP
63.9% more per $
TDUP
-7.0%
-70.9%
CTKB
More free cash flow
CTKB
CTKB
$1.4M more FCF
CTKB
$-1.8M
$-3.2M
TDUP
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
11.1%
TDUP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
TDUP
TDUP
Revenue
$62.1M
$79.7M
Net Profit
$-44.1M
$-5.6M
Gross Margin
52.9%
79.6%
Operating Margin
-9.0%
-8.4%
Net Margin
-70.9%
-7.0%
Revenue YoY
8.1%
18.5%
Net Profit YoY
-557.1%
74.3%
EPS (diluted)
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
TDUP
TDUP
Q4 25
$62.1M
$79.7M
Q3 25
$52.3M
$82.2M
Q2 25
$45.6M
$77.7M
Q1 25
$41.5M
$71.3M
Q4 24
$57.5M
$67.3M
Q3 24
$51.5M
$61.5M
Q2 24
$46.6M
$66.7M
Q1 24
$44.9M
$64.5M
Net Profit
CTKB
CTKB
TDUP
TDUP
Q4 25
$-44.1M
$-5.6M
Q3 25
$-5.5M
$-4.2M
Q2 25
$-5.6M
$-5.2M
Q1 25
$-11.4M
$-5.2M
Q4 24
$9.6M
$-21.7M
Q3 24
$941.0K
$-24.8M
Q2 24
$-10.4M
$-14.0M
Q1 24
$-6.2M
$-16.6M
Gross Margin
CTKB
CTKB
TDUP
TDUP
Q4 25
52.9%
79.6%
Q3 25
52.7%
79.4%
Q2 25
52.3%
79.5%
Q1 25
48.6%
79.1%
Q4 24
58.5%
80.4%
Q3 24
56.3%
79.3%
Q2 24
54.6%
78.8%
Q1 24
51.3%
80.1%
Operating Margin
CTKB
CTKB
TDUP
TDUP
Q4 25
-9.0%
-8.4%
Q3 25
-17.6%
-5.3%
Q2 25
-23.3%
-6.8%
Q1 25
-36.1%
-7.6%
Q4 24
5.2%
-12.1%
Q3 24
-8.2%
-17.0%
Q2 24
-18.3%
-14.4%
Q1 24
-23.9%
-19.2%
Net Margin
CTKB
CTKB
TDUP
TDUP
Q4 25
-70.9%
-7.0%
Q3 25
-10.5%
-5.2%
Q2 25
-12.2%
-6.7%
Q1 25
-27.5%
-7.3%
Q4 24
16.8%
-32.3%
Q3 24
1.8%
-40.3%
Q2 24
-22.4%
-20.9%
Q1 24
-13.8%
-25.7%
EPS (diluted)
CTKB
CTKB
TDUP
TDUP
Q4 25
$-0.06
Q3 25
$-0.03
Q2 25
$-0.04
Q1 25
$-0.04
Q4 24
$-0.19
Q3 24
$-0.22
Q2 24
$-0.13
Q1 24
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
TDUP
TDUP
Cash + ST InvestmentsLiquidity on hand
$90.9M
$38.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$59.2M
Total Assets
$461.5M
$167.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
TDUP
TDUP
Q4 25
$90.9M
$38.6M
Q3 25
$93.3M
$46.2M
Q2 25
$75.5M
$41.0M
Q1 25
$95.3M
$41.1M
Q4 24
$98.7M
$31.9M
Q3 24
$162.3M
$43.7M
Q2 24
$177.9M
$44.8M
Q1 24
$168.8M
$50.1M
Stockholders' Equity
CTKB
CTKB
TDUP
TDUP
Q4 25
$341.7M
$59.2M
Q3 25
$378.6M
$59.1M
Q2 25
$377.6M
$60.2M
Q1 25
$379.6M
$56.1M
Q4 24
$395.7M
$56.3M
Q3 24
$385.5M
$69.3M
Q2 24
$389.1M
$86.5M
Q1 24
$392.6M
$93.5M
Total Assets
CTKB
CTKB
TDUP
TDUP
Q4 25
$461.5M
$167.2M
Q3 25
$494.9M
$172.5M
Q2 25
$493.3M
$173.6M
Q1 25
$482.6M
$172.5M
Q4 24
$499.5M
$171.2M
Q3 24
$491.2M
$214.9M
Q2 24
$483.7M
$231.2M
Q1 24
$492.1M
$244.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
TDUP
TDUP
Operating Cash FlowLast quarter
$-771.0K
$-1.5M
Free Cash FlowOCF − Capex
$-1.8M
$-3.2M
FCF MarginFCF / Revenue
-2.9%
-4.0%
Capex IntensityCapex / Revenue
1.6%
2.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$180.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
TDUP
TDUP
Q4 25
$-771.0K
$-1.5M
Q3 25
$-3.9M
$6.0M
Q2 25
$108.0K
$344.0K
Q1 25
$-125.0K
$5.7M
Q4 24
$2.0M
$663.0K
Q3 24
$13.2M
$3.3M
Q2 24
$6.2M
$-5.0M
Q1 24
$4.0M
$1.4M
Free Cash Flow
CTKB
CTKB
TDUP
TDUP
Q4 25
$-1.8M
$-3.2M
Q3 25
$-4.6M
$2.4M
Q2 25
$-1.5M
$-2.9M
Q1 25
$-974.0K
$3.9M
Q4 24
$1.1M
$-1.8M
Q3 24
$12.2M
$1.2M
Q2 24
$5.2M
$-5.8M
Q1 24
$3.4M
$267.0K
FCF Margin
CTKB
CTKB
TDUP
TDUP
Q4 25
-2.9%
-4.0%
Q3 25
-8.7%
2.9%
Q2 25
-3.2%
-3.8%
Q1 25
-2.3%
5.5%
Q4 24
1.9%
-2.7%
Q3 24
23.7%
2.0%
Q2 24
11.0%
-8.7%
Q1 24
7.6%
0.4%
Capex Intensity
CTKB
CTKB
TDUP
TDUP
Q4 25
1.6%
2.2%
Q3 25
1.3%
4.4%
Q2 25
3.5%
4.2%
Q1 25
2.0%
2.5%
Q4 24
1.6%
3.7%
Q3 24
2.0%
3.5%
Q2 24
2.3%
1.3%
Q1 24
1.3%
1.7%
Cash Conversion
CTKB
CTKB
TDUP
TDUP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

TDUP
TDUP

Segment breakdown not available.

Related Comparisons